Curt R. Hartman Net Worth

The estimated Net Worth of Curt R Hartman is at least $12.5 Million dollars as of 15 June 2023. Mr Hartman owns over 1,000 units of Conmed stock worth over $315,418 and over the last 16 years he sold CNMD stock worth over $10,393,937. In addition, he makes $1,787,620 as Chairman and CEO & Pres at Conmed.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Mr Hartman CNMD stock SEC Form 4 insiders trading

Mr has made over 34 trades of the Conmed stock since 2010, according to the Form 4 filled with the SEC. Most recently he sold 1,000 units of CNMD stock worth $136,000 on 15 June 2023.

The largest trade he's ever made was exercising 136,000 units of Conmed stock on 25 November 2020 worth over $5,422,320. On average, Mr trades about 11,728 units every 102 days since 2009. As of 15 June 2023 he still owns at least 4,299 units of Conmed stock.

You can see the complete history of Mr Hartman stock trades at the bottom of the page.

Mr. Curt R. Hartman biography

Curt R. Hartman is the Chairman, CEO & Pres at Conmed.

What is the salary of Mr Hartman?

As the Chairman and CEO & Pres of Conmed, the total compensation of Mr Hartman at Conmed is $1,787,620. There are no executives at Conmed getting paid more.

How old is Mr Hartman?

Mr Hartman is 57, he's been the Chairman and CEO & Pres of Conmed since . There are 2 older and 6 younger executives at Conmed. The oldest executive at Conmed Corp. is David R. Murray, 73, who is the Pres of ConMed Electrosurgery.

What's Mr Hartman's mailing address?

Curt's mailing address filed with the SEC is C/O CONMED CORP, 11311 CONCEPT BOULEVARD, LARGO, FL, 33773.

Insiders trading at Conmed

Over the last 21 years, insiders at Conmed have traded over $105,028,573 worth of Conmed stock and bought 56,468 units worth $2,754,510 . The most active insiders traders include Jerome J. Lande, Joseph J Corasanti, and Dirk Kuyper. On average, Conmed executives and independent directors trade stock every 8 days with the average trade being worth of $759,159. The most recent stock trade was executed by Charles Farkas on 5 September 2024, trading 1,000 units of CNMD stock currently worth $39,640.

What does Conmed do?

conmed corporation is a global medical technology company that specializes in the development and sale of surgical and patient monitoring products and services that allow our physician customers to deliver high quality care and as a result, enhanced clinical outcomes for their patients. our products are technological leaders in the specialties that we serve: orthopaedics, general surgery, gynecology, gastroenterology, pulmonology, and anesthesiology. conmed's mission, and the focus of every employee around the world, is to improve the quality of health care by designing, producing and marketing innovative, high-quality products. our emphasis is on our customer’s satisfaction and on our enhanced patient outcomes. we strive to demonstrate thoughtful leadership, provide meaningful opportunities for employees, and be a responsible member of the local communities in which we conduct business. conmed is headquartered in beautiful, upstate new york (utica), and employs approximately 3500

Complete history of Mr Hartman stock trades at Conmed, Stryker, and Conmed

Conmed executives and stock owners

Conmed executives and other stock owners filed with the SEC include:

• Curt R. Hartman,
  Chairman, CEO & Pres
• Patrick J. Beyer,
  Pres of International & Global Orthopedics
• Todd W. Garner,
  Exec. VP & CFO
• Stanley W. Peters III,
  VP & GM of U.S. Advanced Surgical
• John E. Kennedy,
  Group Exec. VP of Advanced Endoscopic Technologies, QA/RA, Distribution & Customer Service
• David R. Murray,
  Pres of ConMed Electrosurgery
• Shanna L. Cotti-Osmanski,
  Exec. VP of Information Technology & CIO
• Heather L. Cohen,
  Exec. VP of HR
• Peter K. Shagory,
  Exec. VP of Strategy & Corp. Devel.
• Daniel S. Jonas,
  Exec. VP of Legal Affairs, Gen. Counsel & Sec.
• Charles Farkas,
  Director
• Brian Concannon,
  Director
• David M Bronson,
  Director
• Martha Goldberg Aronson,
  Director
• Nathan Folkert,
  VP GM Orthopedics
• Peter K Shagory,
  EVP, STRAT & CORP DEVT
• John L Workman,
  Director
• Mark E Tryniski,
  Director
• Jo Ann Golden,
  Director
• John Jed Kennedy,
  Group Executive Vice President
• Wilfredo Ruiz Caban,
  EVP QA, RA and Operations
• Jerome J. Lande,
  Director
• Dirk Kuyper,
  Director
• Daniel S Jonas,
  Special Counsel & Corp Secy
• Johonna Marie Pelletier,
  Treasurer and VP, Tax
• Todd W Garner,
  Executive Vice President & CFO
• La Verne H Council,
  Director
• Terence M Berge,
  VP-Corporate Controller
• Luke A Pomilio,
  Vice President
• Barbara J Schwarzentraub,
  Director
• William Matthews,
  Director
• William Abraham,
  SENIOR VICE PRESIDENT
• Stuart J Schwartz,
  Director
• Mark D Snyder,
  EVP Mfg. Operations & Supply
• Gregory Renard Jones,
  Vice President-Corporate QA/RA
• Stephen Mandia,
  Director
• Joseph G Darling,
  President Conmed Linvatec
• Bruce Daniels,
  Director
• David Allen Johnson,
  VP - Global Operations
• Frank R Williams,
  Vice President
• Jane E Metcalf,
  VP Corp. Regulatory Affairs
• Thomas Acey,
  Secretary/Treasurer
• Dennis M Werger,
  Gen. Man. of CONMED Endo Tech
• John J Stotts,
  VICE PRESIDENT
• Alexander Jones,
  Vice President/Corporate Sales
• Gerald G Woodard,
  PRESIDENT- LINVATEC
• David R Murray,
  President - Electrosurgery
• Robert Remmell,
  Director
• Robert D Jr Shallish,
  Vice President/Finance/CFO
• Eugene Starr,
  President/Electrosurgery
• Eugene R Corasanti,
  Chairman of the Board and CEO
• Joseph J Corasanti,
  President & CEO
• Curt R Hartman,
  President, CEO and Chair
• Heather L Cohen,
  EVP & Chief HR & Legal Officer
• John D. Ferrell,
  Executive Vice President - HR
• Pat Beyer,
  Chief Operating Officer
• Jaclyn Peterson,
  VP of Mfg. & Adv. Engineering
• Edward A. Clifford,
  VP Global Manufacturing
• Brent Lalomia,
  Vice President QA and RA
• Stanley W Iii Peters,
  President AS and AET